News
Press Releases
ImmunSYS Announces Upcoming Presentation at AACR Virtual Annual Meeting II
FORT LAUDERDALE, Florida, May 15, 2020 — (BUSINESS WIRE) — ImmunSYS, Inc., a clinical- stage biopharmaceutical company focused on the development of innovative cancer immunotherapy
ImmunSYS Welcomes George C. Prendergast, PhD, a Renowned
Cancer Immunology Expert, to its Scientific Advisory Board
FORT LAUDERDALE, Florida, June 11, 2020 — ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products, announced today the
50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
– In 18 evaluable patients with metastatic prostate cancer, 50% had a
ImmunSYS Announces it Hosted a Virtual Analyst Day Event on July 7, 2020
FORT LAUDERDALE, Florida, July 13, 2020 — ImmunSYS, Inc., a clinical-stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products, today announced that
News
ImmunSYS, Inc. Presents at the BIO International Convention
FORT LAUDERDALE, FL–June 6, 2019–ImmunSYS, Inc. announced today that Chairman & CEO Eamonn Hobbs presented on June 3rd at the 2019 BIO International Conference, held
ImmunSYS Presents at the 2020 BIO CEO & Investor Conference
FORT LAUDERDALE, FL – FEBRUARY 13, 2020 – ImmunSYS announced today that Charles Link, M.D., President and Chief Medical Officer, presented this week on February
June is Cancer Immunotherapy Month
Immunotherapy is considered to be one of the most promising therapies in the effort to cure cancer. It works by enhancing the body’s own immune
